Zonisamide

Phase 3Completed

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Partial Seizures

Conditions

Partial Seizures

Trial Timeline

Jul 1, 2008 → Mar 1, 2012

NCT ID

NCT01136954

About Zonisamide

Zonisamide is a phase 3 stage product being developed by Eisai for Partial Seizures. The current trial status is completed. This product is registered under clinical trial identifier NCT01136954. Target conditions include Partial Seizures.

What happened to similar drugs?

18 of 20 similar drugs in Partial Seizures were approved

Approved (18) Terminated (5) Active (2)

✅Perampanel + PlaceboEisaiApproved

✅Adjunctive Zonisamide + Replacement with ZonisamideEisaiApproved

✅PerampanelEisaiApproved

✅Eslicarbazepine acetate + Eslicarbazepine AcetateSumitomo PharmaApproved

✅OxcarbazepineNovartisApproved

✅Hydrocortisone + PlaceboNovo NordiskApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (6)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01283256	Pre-clinical	Completed	Jan 1, 2011	May 1, 2013	Partial, Generalized and Combined Seizures
NCT01136954	Phase 3	Completed	Jul 1, 2008	Mar 1, 2012	Partial Seizures
NCT00659958	Approved	Completed	Apr 1, 2008	Sep 1, 2009	Epilepsy
NCT01140867	Approved	Completed	Feb 29, 2008	Mar 31, 2011	Epilepsy
NCT00259636	Approved	Withdrawn	Aug 1, 2004	Jan 1, 2008	Fibromyalgia
NCT00056576	Phase 3	Completed	Feb 1, 2002	Oct 1, 2004	Epilepsy, Complex Partial

Competing Products

20 competing products in Partial Seizures

See all competitors

Product	Company	Stage	Hype Score
E2007	Eisai	Phase 3	40
Perampanel	Eisai	Pre-clinical	26
perampanel + perampanel	Eisai	Phase 1	29
perampanel + perampanel + perampanel + Placebo	Eisai	Phase 3	40
Perampanel + Placebo	Eisai	Approved	35
Perampanel and Microgynon-30 + Perampanel and Microgynon-30	Eisai	Phase 1	29
perampanel	Eisai	Phase 2	35
Perampanel	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
zonisamide	Eisai	Pre-clinical	26
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Perampanel + Placebo	Eisai	Phase 3	40
E2007 (perampanel) + E2007 (perampanel) + Placebo	Eisai	Phase 3	40
Adjunctive Zonisamide + Replacement with Zonisamide	Eisai	Approved	43
Fycompa	Eisai	Pre-clinical	26
Zonisamide + Placebo	Eisai	Phase 3	40
Fycompa	Eisai	Pre-clinical	26
Rufinamide	Eisai	Phase 3	32
Zonisamide	Eisai	Phase 3	40
Eslicarbazepine Acetate tablets	Eisai	Pre-clinical	26